fluorodeoxyglucose f18 has been researched along with Thoracic Diseases in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (30.77) | 29.6817 |
| 2010's | 8 (61.54) | 24.3611 |
| 2020's | 1 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Basu, S; Kalshetty, A | 1 |
| Gerbaudo, VH; Wachsmann, JW | 1 |
| Chae, EJ; Do, KH; Hwang, HJ; Kim, EY; Kim, JE; Koo, HJ; Lee, HJ; Oh, SY | 1 |
| Abbott, GF; Carter, BW; Lichtenberger, JP | 1 |
| Alavi, A; Basu, S; Saboury, B; Werner, T | 1 |
| Bordenave, L; de Clermont, H; Laffon, E | 1 |
| Bankier, AA; Eisenberg, RL; Molinari, F | 1 |
| Alavi, A; Kwee, TC; Torigian, DA | 2 |
| Adam, LE; Alavi, A; Alberini, JL; Bhargava, P; Gupta, N; Hickeson, M; Zhuang, H | 1 |
| Chen, MY; Clark, PB; Kavanagh, PV; Stevenson, AW | 1 |
| Fahy, RJ; King, M | 1 |
| Hsu, PK; Hsu, WH | 1 |
10 review(s) available for fluorodeoxyglucose f18 and Thoracic Diseases
| Article | Year |
|---|---|
PET/Computed Tomography in Pulmonary and Thoracic Inflammatory Diseases (Including Cardiac Sarcoidosis): The Current Role and Future Promises.
Topics: Arteritis; Cardiomyopathies; Diagnosis, Differential; Fluorodeoxyglucose F18; Histiocytic Necrotizing Lymphadenitis; Humans; Lupus Erythematosus, Systemic; Organometallic Compounds; Positron Emission Tomography Computed Tomography; Pulmonary Disease, Chronic Obstructive; Radiopharmaceuticals; Sarcoidosis; Sensitivity and Specificity; Thoracic Diseases | 2020 |
Thorax: normal and benign pathologic patterns in FDG-PET/CT imaging.
Topics: Amyloidosis; Fluorodeoxyglucose F18; Gastrointestinal Diseases; Heart Diseases; Humans; Infections; Lung Diseases; Mediastinal Diseases; Multimodal Imaging; Myocardium; Pleural Diseases; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis; Spinal Diseases; Thoracic Diseases; Thoracic Injuries; Thoracic Vertebrae; Thorax; Tissue Distribution; Tomography, X-Ray Computed | 2014 |
Pitfalls in imaging of the chest wall.
Topics: Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Thoracic Diseases; Thoracic Wall; Tomography, X-Ray Computed | 2015 |
Clinical utility of FDG-PET and PET/CT in non-malignant thoracic disorders.
Topics: Drug Monitoring; Fluorodeoxyglucose F18; Humans; Inflammation; Multimodal Imaging; Positron-Emission Tomography; Thoracic Diseases; Tomography, X-Ray Computed | 2011 |
[PET-CT in thoracic disease].
Topics: Bronchial Diseases; Contraindications; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Diseases; Mediastinal Diseases; Neoplasm Recurrence, Local; Neoplasm Staging; Pleural Diseases; Positron-Emission Tomography; Pregnancy; Radiopharmaceuticals; Thoracic Diseases; Tomography, X-Ray Computed | 2010 |
Fat-containing lesions in adult thoracic imaging.
Topics: Adipose Tissue; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Neoplasms, Adipose Tissue; Positron-Emission Tomography; Radiography, Thoracic; Radiopharmaceuticals; Thoracic Diseases; Thoracic Neoplasms; Tomography, X-Ray Computed | 2011 |
Overview of positron emission tomography, hybrid positron emission tomography instrumentation, and positron emission tomography quantification.
Topics: Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Thoracic Diseases; Tomography, X-Ray Computed | 2013 |
Nononcological applications of positron emission tomography for evaluation of the thorax.
Topics: Atherosclerosis; Fluorodeoxyglucose F18; Humans; Idiopathic Interstitial Pneumonias; Infections; Positron-Emission Tomography; Pulmonary Disease, Chronic Obstructive; Radiopharmaceuticals; Respiratory Distress Syndrome; Sarcoidosis; Thoracic Diseases; Thorax | 2013 |
Positron emission tomography imaging in nonmalignant thoracic disorders.
Topics: Animals; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Infections; Inflammation; Lymph Nodes; Lymphatic Diseases; Pleural Diseases; Radiopharmaceuticals; Solitary Pulmonary Nodule; Thoracic Diseases; Tomography, Emission-Computed | 2002 |
Nonneoplastic diseases in the chest showing increased activity on FDG PET.
Topics: Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Radiopharmaceuticals; Thoracic Diseases; Tomography, Emission-Computed | 2004 |
3 other study(ies) available for fluorodeoxyglucose f18 and Thoracic Diseases
| Article | Year |
|---|---|
Presence of macronodules in thoracic sarcoidosis: prevalence and computed tomographic findings.
Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Diseases; Male; Middle Aged; Peptidyl-Dipeptidase A; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sarcoidosis; Thoracic Diseases; Tomography, X-Ray Computed | 2015 |
Fluorodeoxyglucose F 18 positron emission tomography scanning in thoracic disease.
Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron-Emission Tomography; Solitary Pulmonary Nodule; Thoracic Diseases | 2004 |
Chest wall mass caused by salmonella enteritidis - a pitfall of PET imaging interpretation.
Topics: Aged; Anti-Infective Agents; Breast Neoplasms; Ceftriaxone; Ciprofloxacin; Female; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Salmonella enteritidis; Salmonella Infections; Thoracic Diseases; Thoracic Wall; Tomography, X-Ray Computed | 2008 |